HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Role of liver transplantation in urea cycle disorders: Report from a nationwide study in Japan.

Abstract
Urea cycle disorders (UCDs) are inherited metabolic diseases causing hyperammonemia by defects in urea cycle enzymes or transporters. Liver transplantation (LT) currently is the only curative treatment option until novel therapies become available. We performed a nationwide questionnaire-based study between January 2000 and March 2018 to investigate the effect of LT in patients with UCDs in Japan. A total of 231 patients with UCDs were enrolled in this study. Of them, a total of 78 patients with UCDs (30 male and 16 female ornithine transcarbamylase deficiency (OTCD), 21 carbamoyl phosphate synthetase 1 deficiency (CPSD), 10 argininosuccinate synthetase deficiency (ASSD) and 1 arginase 1 deficiency (ARGD)) had undergone LT. Concerning the maximum blood ammonia levels at the onset time in the transplanted male OTCD (N = 28), female OTCD (N = 15), CPSD (N = 21) and ASSD (N = 10), those were median 634 (IQR: 277-1172), 268 (211-352), 806 (535-1382), and 628 (425-957) μmol/L, respectively. The maximum blood ammonia levels in female OTCD were thus significantly lower than in the other UCDs (all P < .01). LT was effective for long-term survival, prevented recurrent hyperammonemia attack, and lowered baseline blood ammonia levels in patients with UCDs. LT had limited effect for ameliorating neurodevelopmental outcome in patients with severe disease because hyperammonemia at the onset time already had a significant impact on the brain. Patients with ASSD may be more likely to survive without cognitive impairment by receiving early LT despite severe neonatal hyperammonemia ≥ 360 μmol/L. In patients with neonatal onset OTCD or CPSD, there may be additional factors with adverse effects on the brain that are not improved by LT.
AuthorsJun Kido, Shirou Matsumoto, Johannes Häberle, Yukihiro Inomata, Mureo Kasahara, Seisuke Sakamoto, Reiko Horikawa, Akihiro Tanemura, Hideaki Okajima, Tatsuya Suzuki, Kimitoshi Nakamura
JournalJournal of inherited metabolic disease (J Inherit Metab Dis) Vol. 44 Issue 6 Pg. 1311-1322 (11 2021) ISSN: 1573-2665 [Electronic] United States
PMID34232532 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2021 SSIEM.
Topics
  • Adolescent
  • Brain (metabolism)
  • Child
  • Child Development (physiology)
  • Child, Preschool
  • Female
  • Humans
  • Infant
  • Infant, Newborn
  • Japan
  • Liver Transplantation
  • Male
  • Survival Rate
  • Treatment Outcome
  • Urea Cycle Disorders, Inborn (metabolism, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: